Skip to main content
SpringerLink
Log in

Managing Schizophrenia

Interventions and Outcomes

  • Review Article
  • Interventions & Outcomes
  • Published:
Disease Management & Health Outcomes

Summary

The time has come for the development of standards to ensure quality and cost-effective care for the treatment of people with schizophrenia. Advances in understanding the efficacy of treatments for schizophrenia, the promise of new treatment advances derived from a rapidly evolving neuroscience, pressures to contain healthcare costs while maintaining or increasing quality, and the growth of advocacy on behalf of persons with schizophrenia are driving this need.

The evidence for the efficacy of pharmacotherapies, psychological interventions, family interventions, vocational rehabilitation, and case management and assertive community treatment is summarised. This article presents the implications of the evidence for instituting disease management programmes for schizophrenia. Such disease management programmes must ensure that efficacious treatments are available, that both effectiveness and costs are considered in the allocation of resources, and that evaluative systems are in place to promote ongoing learning about how to provide the best care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McGlashan TH. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 1988; 14: 515–42

    Article  PubMed  CAS  Google Scholar 

  2. Ram R, Bromet E, Eaton W, et al. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992; 18: 185–207

    Article  PubMed  CAS  Google Scholar 

  3. Norquist GS, Regier DA, Rupp A. Estimates of the cost of treating people with schizophrenia: contributions of data from epidemiologic surveys. In: Moscarelli M, Rupp A, Sartorius N, et al., editors. Handbook of mental health economics and health policy. Vol. 1. Schizophrenia. New York: John Wiley &Sons, 1996: 95–101

    Google Scholar 

  4. Rupp A, Keith S. The costs of schizophrenia: assessing the burden. Psychiatr Clin North Am 1993; 16: 413–23

    PubMed  CAS  Google Scholar 

  5. Lehman A. Evaluating outcomes of treatment for persons with psychotic disorders. J Clin Psychiatry 1996; 57: 61–7

    PubMed  Google Scholar 

  6. Lehman AF, Carpenter WT, Goldman HH. Treatment outcomes in schizophrenia: implications for practice, policy, and research. Schizophr Bull 1995; 21: 669–75

    Article  PubMed  CAS  Google Scholar 

  7. Attkisson C, Cook J, Karno M, et al. Clinical services research. Schizophr Bull 1992; 18: 561–626

    Article  PubMed  CAS  Google Scholar 

  8. Dixon L, Lehman A, Levine J. Conventional antipsychotic medications for schizophrenia. Schizophr Bull 1995; 21: 567–78

    Article  PubMed  CAS  Google Scholar 

  9. Buchanan R. Clozapine: efficacy and safety. Schizophr Bull 1995; 21: 579–91

    Article  PubMed  CAS  Google Scholar 

  10. Umbricht D, Kane J. Risperidone: efficacy and safety. Schizophr Bull 1995; 21: 593–606

    Article  PubMed  CAS  Google Scholar 

  11. Johns C, Thompson J. Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophr Bull 1995; 21: 607–19

    Article  PubMed  CAS  Google Scholar 

  12. Scott J, Dixon L. Psychological interventions for schizophrenia. Schizophr Bull 1995; 21: 621–30

    Article  PubMed  CAS  Google Scholar 

  13. Dixon L, Lehman A. Family interventions for schizophrenia. Schizophr Bull 1995; 21: 631–43

    Article  PubMed  CAS  Google Scholar 

  14. Lehman A. Vocational rehabilitation in schizophrenia. Schizophr Bull 1995; 21: 645–56

    Article  PubMed  CAS  Google Scholar 

  15. Scott J, Dixon L. Assertive community treatment and case management. Schizophr Bull 1995; 21: 657–68

    Article  PubMed  CAS  Google Scholar 

  16. Lehman AF. Measuring quality of life in a reformed health system. Health Affairs 1995; 14: 90–101

    Article  PubMed  CAS  Google Scholar 

  17. Beasley CM, Tollefson GD, Tran P, et al. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996; 14: 105–10

    Article  Google Scholar 

  18. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994; 151: 825–35

    PubMed  CAS  Google Scholar 

  19. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatmentresistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96

    Article  PubMed  CAS  Google Scholar 

  20. Borison RL, Arvantis LA, Miller BG. A comparison of five fixed-doses of ‘Seroquel’ (ICI-204,636) with haloperidol and placebo in patients with schizophrenia (abstract no. V.D.2]. Schizophr Res 1996; 18: 132

    Article  Google Scholar 

  21. Schulz SC, Mack R, Zborowski J, et al. Efficacy, safety, and dose response of three doses of sertindole and three doses of Haldol in schizophrenia patients [abstract]. Schizophr Res 1996; 18: 133

    Article  Google Scholar 

  22. Seeger TF, Seymour PA, Schmidt AW, et al. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 1995; 275: 101–13

    PubMed  CAS  Google Scholar 

  23. Lehman AF. Evaluating outcomes of treatments for persons with psychotic disorders. J Clin Psychiatry 1996; 57 Suppl. 11: 61–7

    PubMed  Google Scholar 

  24. Hogarty GE, Anderson CM, Reiss DJ, et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991; 48: 340–7

    Article  PubMed  CAS  Google Scholar 

  25. McFarlane WR, Lukens E, Link B, et al. Multiple family group and psychoeducation in the treatment os schizophrenia. Arch Gen Psychiatry 1995; 52: 679–87

    Article  PubMed  CAS  Google Scholar 

  26. Klein DF. The utility of guidelines and algorithms for practice. Psychiatr Ann 1994; 24: 362–7

    Google Scholar 

  27. American Psychiatric Association. Practice guideline for treatment of patients with schizophrenia. Am J Psychiatry. In press

  28. Frances A, Docherty J, Kahn DA. The expert consensus guideline series: treatment of schizophrenia. J Clin Psychiatry 1996; 57 Suppl. 12B: 1–58

    Google Scholar 

  29. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of schizophrenia. J Am Acad Child Adolesc Psychiatry 1994; 33: 616–35

    Article  Google Scholar 

  30. McGlynn E. Inpatient treatment of schizophrenia: a literature review and criteria for assessing quality; 1993. RAND monograph: DRU-451-NIMH

  31. Wells K, Brook R. The quality of mental health services: past, present, and future. In: Taube C, Mechanic D, Hohmann A, et al., editors. The future of mental health services research. Washington, DC: US Government Printing Office, 1989: 203–24. DHHS Publ. no. (ADM) 89-1600

    Google Scholar 

  32. Sederer L, Dickey B, editors. Outcomes assessment in clinical practice. Baltimore: Williams & Wilkins, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Maryland, Center for Mental Health Services Research, Baltimore, Maryland, USA

    Anthony F. Lehman

Authors
  1. Anthony F. Lehman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony F. Lehman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehman, A.F. Managing Schizophrenia. Dis Manage Health Outcomes 1, 286–295 (1997). https://doi.org/10.2165/00115677-199701060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199701060-00002

Search

Navigation